Energy
57/100
57/100Is LEU-Centrus Energy a buy?
Tuesday 14 July 2026
Why now: The stock is repricing sharply in the overnight session (last trade $156.39, down 8.6% versus the $171.11 prior close), which often reflects either a headline-driven reset or a crowded positioning unwind. Separate from the tape, the company has very recent contract confirmation with the DOE that anchors the long-dated commercial-scale HALEU buildout narrative.
Upside: If execution and funding stay on track, the upside is mainly a multi-year re-rating tied to turning government-backed milestones into durable commercial earnings power; analyst target ranges cited by market data providers imply meaningful 12-month upside from recent regular-session prices, but results can be very path-dependent. A more conservative upside frame for a 1+ year holder is: the name can recover much of the current gap if the next earnings update supports timeline and margin confidence.
Risks: The main risk is execution and schedule risk on a long-dated enrichment capacity buildout, where delays, cost inflation, or contracting changes can hit confidence fast. A second risk is valuation compression: if earnings normalize lower or investors rotate away from nuclear-fuel-cycle themes, multiples can fall even if the long-term story remains intact.
Scorecard
Read:Strong metricsSolid metricsSelectiveCautionUnfavourableN/A
| Scorecard | 57/100 | |
|---|---|---|
| Company Detail | LEU - Centrus Energy Corp. | |
| Price as at 13 July 2026 | $156.05 | |
| Market cap | $3.1B | |
| Quality and Fundamental Score (100) | ||
| Breakout / Early-Momentum /20 | 0/20 | |
| Rev/EPS Momentum /20 | 13/20 | |
| Business Quality /15 | 12/15 | |
| Balance Sheet /15 | 15/15 | |
| Valuation /10 | 4/10 | |
| Industry Relative Strength /10 | 3/10 | |
| Macro / Sector Tailwind /10 | 10/10 | |
| Growth (mechanical) | ||
| Cash runway | Cash generative | |
| Revenue YoY | +1.5% | |
| EPS YoY | -12.8% | |
| FCF YoY | -4.9% | |
| Gross margin | 26.2% | |
| Valuation & Trend | ||
| Trailing P/E | 62.2x | |
| Forward P/E | 39.6x | |
| RSI (14d) | 42 | |
| vs 50d SMA | -13.3% | |
| Support cushion | −7.3% | |
| Sentiment | ||
| Wall Street verdict | Mixed | |
| News tone | Quiet | |
| Dividend | — | |
How are these colored?
| Metric | Strong metrics | Solid metrics | Selective | Caution | Unfavourable |
|---|---|---|---|---|---|
| Overall score | ≥ 80 | 70-79 | 60-69 | 50-59 | < 50 |
| Business quality /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Balance sheet /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Market cap | ≥ $20B | $5B-$20B | $2B-$5B | $1B-$2B | < $1B |
| Cash runway | ≥ 3 yr or cash generative | 1.5-3 yr | 0.75-1.5 yr | 0.25-0.75 yr | < 0.25 yr |
| Revenue YoY | ≥ 15% | 5-15% | 0-5% | -5-0% | < -5% |
| EPS YoY | ≥ 20% | 5-20% | 0-5% | -5-0% | < -5% |
| FCF YoY | ≥ 10% | 1-10% | 0-1% | -5-0% | < -5% |
| Gross margin | ≥ 60% | 40-60% | 25-40% | 10-25% | < 10% |
| Trailing P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| Forward P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| RSI (14d) | 50-70 | 45-50 or 70-75 | 40-45 or 75-78 | 30-40 or 78-80 | < 30 or > 80 |
| vs 50d SMA | +2% to +15% | 0-2% or 15-25% | -2-0% or 25-35% | -3--2% or 35-40% | < -3% or > 40% |
| Support cushion | 2-10% above | 0-2% | 10-15% | 15-20% | price below support |
| Wall Street verdict | Aligned | — | Mixed | — | Disagrees |
| News tone | Positive | — | Neutral / Mixed | — | Negative |
| Dividend | Yield ≥ 2% & growing | Growing | Flat payer ≥ 1% | Low / flat | Cutting |
Detailed Analysis — Tuesday 14 July 2026
What they do
Centrus Energy supplies nuclear fuel components and services, including enriched uranium products for nuclear power customers, and is building domestic uranium enrichment capacity in the United States. It makes money from contracted fuel supply and services today, and is investing to scale commercial enrichment capacity for both low-enriched uranium and HALEU over time.
Leadership
Amir V. VexlerCEO
Amir V.
Todd M. TinelliCFO
Todd M.
Customers & notable contracts
Receiver of capital expenditure: Yes — A meaningful part of the growth plan is supported by government-funded milestone payments and contract structures that effectively fund capacity buildout and operations tied to deliverables.
Main customers
- U.S. Department of Energy (DOE) / National nuclear programs (Government customer and counterparty for HALEU production and capacity buildout contracts; funding is tied to performance milestones and options.)
- Nuclear utilities and fuel-cycle customers (LEU supply segment) (Commercial customers buying separative work units and uranium deliveries under medium and long-term contracts; Centrus describes a large contracted LEU backlog, with additional contingent commitments tied to future capacity buildout.)
Notable contracts
- DOE HALEU commercial enrichment capacity contract (firm fixed price) — $900 million firm fixed price; includes options priced at $17 million per MTU for up to two 5-MTU option deliveries (Signed June 30, 2026; milestone-based payments; delivery by March 2032 of 1 MTU of HALEU UF6 at nominal 19.75% U-235, with DOE options for additional deliveries.)
Summary thesis
- Centrus sits at a strategically important choke point in the US nuclear fuel supply chain: domestic uranium enrichment capability, including HALEU, which many advanced reactor designs are expected to require.
- The recent DOE contract structure is a concrete step from “pilot” activity toward commercial-scale milestones, and the company has shown it can deliver HALEU under government programs.
- The tradeoff is that a big part of the value rests on multi-year buildout execution and a market that is still early in commercial demand realization.
Wall Street alignment
Wall Street: Mixed signals (2 pos / 1 neg)
Analyst consensus
Buy (1.75, 14 analysts) · +72% upside
Institutional ownership
86% institutions, insiders 4.3%
Short interest
23.3% of float short · 4.6 d-to-cover
Smart money tape
-1 net (acc 1 / dist 2, last 26d)
Recent news
News Quiet · last 7d
Show 2 headlines from the last 7d
2026-07-07Macro+
Centrus Energy says it will join the S&P SmallCap 600 Index effective July 14, 2026 ↗ · Centrus Energy Corp.
Centrus said it is set to be added to the S&P SmallCap 600 Index before the open on July 14, 2026. This can increase index-linked demand and liquidity, but it does not change the company’s underlying contract and production execution path.
2026-07-08Macro+
S&P Dow Jones Indices announces Centrus Energy addition to S&P SmallCap 600 effective July 14, 2026 ↗ · S&P Dow Jones Indices
S&P Dow Jones Indices published the index change showing Centrus Energy will be added to the S&P SmallCap 600 effective July 14, 2026. The announcement supports near-term trading flows but is not a fundamental driver of Centrus’s uranium enrichment capacity expansion or cash generation.
Dividends
Pays no regular dividend.
Technicals
Price
$156.05
RSI (14d)
42.1
50d SMA
$179.98
200d SMA
$242.39
vs 50d SMA
-13.3%
vs 200d SMA
-35.6%
Support (swing low)
$144.65 −7.3%
Next swing high (swing high)
$179.82 +15.2%
Close as of 2026-07-13.
Score breakdown
Scores 57 out of 100 — a mixed overall grade. Balance sheet, sector fit, and business quality scored highest. Earnings trend was fair but not a standout driver. Valuation and relative strength versus its industry weighed on the total. The technical setup is currently poor (no 200-day uptrend signal in the provided tape snapshot, no reclaim/heartbeat, and a large overnight gap down). The overall score is also capped by valuation risk and the reality that a meaningful portion of the upside depends on multi-year execution against government milestones.
Component scores are on the scorecard above.
Momentum evidence
- The provided daily technical snapshot is weak (no confirmed breakout state and the 200-day trend flag is not positive), and industry-relative strength is also below average.
- The overnight print at $156.39 represents a sharp reset versus the prior close, so near-term momentum is clearly negative and the stock likely needs time to rebuild investor confidence through follow-through news and clean quarterly execution.
Fundamental evidence
- Centrus reported full-year 2025 revenue of $448.7 million, gross profit of $117.5 million, and net income of $77.8 million, and it highlighted a strengthened balance sheet with $2.0 billion of unrestricted cash at year-end 2025.
- In early July 2026 it disclosed a firm fixed price $900 million DOE contract with milestone payments to deploy new domestic commercial HALEU enrichment capacity at Piketon, with delivery obligations running out to March 2032 and DOE options for additional deliveries.
- Key red flags to keep in view: a portion of the long-term upside depends on government option exercise, appropriations, and successful scale-up, and the timeline runs multiple years.
- The historical HALEU operations program also shows that production can be constrained by government-furnished equipment and supply chain bottlenecks (for example, storage cylinder availability was previously cited as a limiting factor), which is a reminder that execution is not fully within Centrus’ control.
Cash runway: Cash generative (latest annual free cash flow is positive).
Valuation view
Valuation appears demanding versus near-term earnings power, as market data sources show a high trailing price-to-earnings multiple. The more defensible peer set is the small group of uranium enrichment and nuclear-fuel-cycle providers, where scarcity value can justify higher multiples, but the stock can still de-rate quickly if the market decides the cash flows are too far out or too policy-dependent.
Macro tailwind
US energy security and nuclear supply-chain reshoring are active policy themes, and HALEU availability remains a widely discussed bottleneck for advanced reactor deployment. A firm DOE contract with milestone payments is the kind of policy-to-procurement bridge that can turn a theme into actual funded work.
What to watch
Upcoming (1–6 months)
- Next quarterly earnings update (market sources show an after-close earnings date in August 2026) for any changes to 2026 guidance, milestone timing, and spend plans tied to the DOE contract.
Ongoing
- Progress against DOE milestone payments and any contract modifications, plus updates on commercial customer commitments that convert from contingent to firm orders.
Long-term case
Over a multi-year horizon, the bull case is that Centrus becomes the core domestic supplier of enrichment services and HALEU in a world where nuclear demand, reactor life extensions, and advanced reactor deployments lift fuel-cycle spending. The company’s long-term value rests on converting government-backed scale-up into repeatable commercial operations, defending its position against global incumbents, and translating contracted backlog and options into durable, high-quality earnings and cash flow.
Risks & invalidation
Risks
- Policy and funding risk: appropriations, changing priorities, or procurement delays could slow milestone payments, reduce option exercise, or shift economics.
- Execution risk: cost inflation, schedule slips, or supply chain constraints could push out the commercialization timeline and compress returns on invested capital.
Breaks the thesis
- A clear management or DOE disclosure that the commercial HALEU capacity buildout is delayed materially beyond stated milestone plans, de-scoped, or no longer expected to transfer into commercially controlled capacity after completion.
Bottom line
Centrus is a real operating business in a strategically important niche: domestic uranium enrichment, including HALEU, where the United States is trying to rebuild capacity and the DOE is now signing larger, milestone-based contracts. The long-term case is credible, but it is still execution-heavy and policy-linked, and today’s sharp overnight drop shows how quickly the market can reprice that risk. The swing factor over a 1+ year hold is whether the company consistently turns contract milestones and backlog into predictable commercial cash earnings without new timeline or cost surprises.